B7-H3 is an immune checkpoint molecule with limited expression in normal tissues (21) which has most commonly been associated with inhibition of cytotoxic CD8+ T lymphocyte activation (22) by tumor cells presenting tumor antigens on HLA class I antigen complexes. This evidence concerns the gene CD8A and neoplasm.